These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8063280)
21. An animal model for Epstein-Barr virus (EBV)-associated lymphomagenesis in the human: malignant lymphoma induction of rabbits by EBV-related herpesvirus from cynomolgus. Hayashi K; Akagi T Pathol Int; 2000 Feb; 50(2):85-97. PubMed ID: 10792766 [TBL] [Abstract][Full Text] [Related]
22. Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphoma. Kon S; Sato T; Onodera K; Satoh M; Kikuchi K; Imai S; Osato T Pathol Res Pract; 1993 Dec; 189(10):1137-44. PubMed ID: 8183733 [TBL] [Abstract][Full Text] [Related]
23. Malignant lymphoma of the thyroid. A 30-year clinicopathologic experience and an evaluation of the presence of Epstein-Barr virus. Lam KY; Lo CY; Kwong DL; Lee J; Srivastava G Am J Clin Pathol; 1999 Aug; 112(2):263-70. PubMed ID: 10439808 [TBL] [Abstract][Full Text] [Related]
24. Malignant lymphoma induction of rabbits with oral spray of Epstein-Barr virus-related herpesvirus from Si-IIA cells (HTLV-II-transformed Cynomolgus cell line): a possible animal model for Epstein-Barr virus infection and subsequent virus-related tumors in humans. Koirala TR; Hayashi K; Chen HL; Ino H; Kariya N; Yanai H; Choudhury CR; Akagi T Pathol Int; 1997 Jul; 47(7):442-8. PubMed ID: 9234382 [TBL] [Abstract][Full Text] [Related]
25. Incidence of Epstein-Barr virus in AIDS-related lymphoma specimens. Samoszuk M; Nguyen V; Shadan FF; Ramzi E J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):913-8. PubMed ID: 8391077 [TBL] [Abstract][Full Text] [Related]
26. Sporadic activation of Epstein-Barr virus in thyroid lymphoma. Tomita Y; Ohsawa M; Kanno H; Matsuzuka F; Kuma K; Aozasa K Leuk Lymphoma; 1995 Sep; 19(1-2):129-34. PubMed ID: 8574157 [TBL] [Abstract][Full Text] [Related]
27. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment. Shields DJ; Byrd JC; Abbondanzo SL; Lichy JH; Diehl LF; Aguilera NI Mod Pathol; 1997 Nov; 10(11):1151-9. PubMed ID: 9388067 [TBL] [Abstract][Full Text] [Related]
28. No significant role of Epstein-Barr virus in the tumorigenesis of Warthin tumor. Ogata T; Hongfang Y; Kayano T; Hirai K J Med Dent Sci; 1997 Jun; 44(2):45-52. PubMed ID: 9608281 [TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus (EBV) genomes and EBV-encoded latent membrane protein (LMP) in pulmonary lymphomas occurring in nonimmunocompromised patients. Sabourin JC; Kanavaros P; Briere J; Lescs MC; Petrella T; Zafrani ES; Gaulard P Am J Surg Pathol; 1993 Oct; 17(10):995-1002. PubMed ID: 8396858 [TBL] [Abstract][Full Text] [Related]
30. Lymphomatoid granulomatosis: evidence that some cases represent Epstein-Barr virus-associated B-cell lymphoma. Nicholson AG; Wotherspoon AC; Diss TC; Singh N; Butcher DN; Pan LX; Isaacson PG; Corrin B Histopathology; 1996 Oct; 29(4):317-24. PubMed ID: 8910039 [TBL] [Abstract][Full Text] [Related]
31. Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review. Anagnostopoulos I; Hummel M; Stein H Leuk Lymphoma; 1995 Sep; 19(1-2):1-12. PubMed ID: 8574154 [TBL] [Abstract][Full Text] [Related]
32. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis. Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384 [TBL] [Abstract][Full Text] [Related]
33. Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses. Lacoste V; Judde JG; Bestett G; Cadranel J; Antoine M; Valensi F; Delabesse E; Macintyre E; Gessain A Leuk Lymphoma; 2000 Jul; 38(3-4):401-9. PubMed ID: 10830748 [TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus and the lacrimal gland pathology of Sjögren's syndrome. Pflugfelder SC; Crouse CA; Monroy D; Yen M; Rowe M; Atherton SS Am J Pathol; 1993 Jul; 143(1):49-64. PubMed ID: 8391219 [TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153 [TBL] [Abstract][Full Text] [Related]
36. Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection. Barletta JM; Kingma DW; Ling Y; Charache P; Mann RB; Ambinder RF Mol Cell Probes; 1993 Apr; 7(2):105-9. PubMed ID: 8391639 [TBL] [Abstract][Full Text] [Related]
37. Criteria for the definition of Epstein-Barr virus association in Hodgkin's disease. Armstrong AA; Weiss LM; Gallagher A; Jones DB; Krajewski AS; Angus B; Brown G; Jack AS; Wilkins BS; Onions DE Leukemia; 1992 Sep; 6(9):869-74. PubMed ID: 1325580 [TBL] [Abstract][Full Text] [Related]
38. Down-regulation of Epstein-Barr virus nuclear antigen 1 in Reed-Sternberg cells of Hodgkin's disease. Khan G; Naase MA J Clin Pathol; 1995 Sep; 48(9):845-8. PubMed ID: 7490319 [TBL] [Abstract][Full Text] [Related]